Primary Vs. Postchemotherapy Retroperitoneal Lymph Node Dissection For Germ Cell And Testicular Cancer: Inter-and Postoperative Complications
Main Category: Urology / NephrologyAlso Included In: Cancer / Oncology
Article Date: 15 Jun 2008 - 6:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
ORLANDO, FL (UroToday.com) - The authors examined their series of 216 patients with testis cancer who underwent retroperitoneal lymph node dissection (RPLND). 117 patients had primary-RPLND (P-RPLND), while 99 patients were subjected to post-chemotherapy dissections (PC-RPLND). The authors compared clinical data from the P-RPLND group and the PC-RPLND patients. Blood loss was higher in the PC-RPLND group (1,500 cc vs 600 cc, p<0.0001). PC-RPLNDs was also a longer operation (353 minutes vs 279 minutes, p<0.0001). No statistical difference was seen in major vascular injuries (those requiring intraoperative consultation with a vascular surgeon) in the PC-RPLND group (n=11) when compared to the P-RPLND patients (n=6). The authors used a grading scale to classify complications that occurred intraoperatively or within 30 days of surgery:
Grade I - medical management
Grade III - procedure or re-operation needed
Grade IV - chronic disability
Grade V - death
37% of patients who underwent PC-RPLND and 27% of patients following P-RPLND experienced some type of complication. Unlike reports by other groups, this difference did not reach statistical significance. Patients in the PC-RPLND group were more likely to have a non-Grade I complication. Subdivision of complications by grade was as follows:
I Grade P-RPLND 25 (64%) - PC-RPLND 30 (57%)
II Grade P-RPLND 9 (23%) - PC-RPLND 16 (31%)
III Grade P-RPLND 5 (13%) - PC-RPLND 4 (8%)
IV Grade P-RPLND 0 (0%) - PC-RPLND 1 (2%)
V Grade P-RPLND 0 (0%) - PC-RPLND 1 (2%)
Reports such as this from centers that perform high volumes of these difficult and rare operations are very valuable to the urological community at large.
Presented by Vairavan S Subramanian, MD, Carvell T Nguyen, MD, Andrew J Stephenson, MD, and Eric A Klein, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor Alexander Kutikov, MD
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/111252.php>
APA
http://www.medicalnewstoday.com/releases/111252.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



